SGP - Spyglass Pharma, Inc.

Insider Purchase by Yang Rick (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Yang Rick, serving as 10% owner at Spyglass Pharma, Inc. (SGP), purchased 937,500 shares at $16.00 per share, for a total transaction value of $15,000,000.00. Following this transaction, Yang Rick now holds 6,035,038 shares of SGP.

This purchase represents a 18.00% increase in Yang Rick's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, February 9, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 11, 2026, 2 days after the trade was made.

Yang Rick

10%

Rick Yang is a venture capital professional serving as the manager of NEA 17 GP, LLC, which indirectly controls New Enterprise Associates 17, L.P. (NEA 17), a significant investor in SpyGlass Pharma, Inc. (SGP).[[1]](https://www.stocktitan.net/sec-filings/SGP/form-4-spy-glass-pharma-inc-insider-trading-activity-765c05afb450.html)[[5]](https://www.insidermonkey.com/insider-trading/company/spyglass+pharma+inc/1778922/)[[6]](https://insiderinsights.com/free/index.php?s=ticker&o=-1&a=&q=SGP) As a Section 16 reporting person and beneficial owner through NEA 17, he is listed as a corporate insider at SGP, reflecting his influential role in the firm's investment activities.[[1]](https://www.stocktitan.net/sec-filings/SGP/form-4-spy-glass-pharma-inc-insider-trading-activity-765c05afb450.html)[[2]](https://www.ainvest.com/news/insider-purchase-10-owner-director-sgp-bought-3-690-000-shares-2602/) On February 9, 2026, coinciding with SGP's initial public offering, NEA 17 converted its preferred stock (Series B, C-1, C-2, and D) into common shares on a one-for-one basis and purchased an additional 937,500 shares at $16 per share, increasing its holdings to 6,035,038 shares.[[1]](https://www.stocktitan.net/sec-filings/SGP/form-4-spy-glass-pharma-inc-insider-trading-activity-765c05afb450.html)[[2]](https://www.ainvest.com/news/insider-purchase-10-owner-director-sgp-bought-3-690-000-shares-2602/)[[5]](https://www.insidermonkey.com/insider-trading/company/spyglass+pharma+inc/1778922/) Rick Yang disclaims beneficial ownership except to the extent of his pecuniary interest, underscoring his position within the New Enterprise Associates structure.[[1]](https://www.stocktitan.net/sec-filings/SGP/form-4-spy-glass-pharma-inc-insider-trading-activity-765c05afb450.html)

View full insider profile →

Trade Price

$16.00

Quantity

937,500

Total Value

$15,000,000.00

Shares Owned

6,035,038

Trade Date

Monday, February 9, 2026

13 days ago

SEC Filing Date

Wednesday, February 11, 2026

Filed 2 days after trade

About Spyglass Pharma, Inc.

Company Overview

No company information available
View news mentioning SGP

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/3898256

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime